# AdvanCell

- **Section**: news
- **Answer**: AdvanCell: 9 headlines on record, 2 headlines in the last 90 days. Its story counts 4 milestones.
- **As of**: 2026-11-16
- **Cite**: AdvanCell, News. Alion, Nov 16, 2026. https://alion.io/company/advancell/news
- **License**: CC BY-SA 4.0

## Company

- **Id**: 2044873
- **Name**: AdvanCell
- **Domain**: advancell.com.au
- **Url**: <https://alion.io/company/advancell>

## Figures

- Label: Headlines; Value: 9
- Label: In 90 days; Value: 2
- Label: Milestones; Value: 4

## Blocks

- **Headlines** — Key: news; Source: the outlets named on each headline, each story once; Rows: 9
- **Milestones** — Key: story; Source: Each milestone is dated by its source: registers, filings, the press; Rows: 4

## News

- [Growing And Scaling A Radiopharmaceuticals Company With AdvanCell's Philina Lee, Ph.D.](https://lifescienceleader.com/doc/growing-and-scaling-a-radiopharmaceuticals-company-with-advancell-s-philina-lee-ph-d-0001) — Date: 2026-09-28; Kind: News; Source: RFWrightLSL
- [AdvanCell Appoints Sean Cassidy as Chief Financial Officer](https://uk.finance.yahoo.com/news/advancell-appoints-sean-cassidy-chief-120000776.html) — Date: 2026-09-15; Kind: News; Source: YahooFinance
- [PRN_FinancialWrapper](https://markets.financialcontent.com/prnews.pre/article/bizwire-2026-7-15-advancell-closes-us-315-million-oversubscribed-series-d-financing-to-advance-targeted-alpha-therapies-and-expand-clinical-and-commercial-manufacturing-infrastructure) — Date: 2026-07-15; Kind: News; Source: PRNewswire
- [AdvanCell Strengthens Executive Leadership to Accelerate U.S. Expansion and Scale its Global Targeted Alpha Therapy Platform](https://morningstar.com/news/business-wire/20260608208211/advancell-strengthens-executive-leadership-to-accelerate-us-expansion-and-scale-its-global-targeted-alpha-therapy-platform) — Date: 2026-06-08; Kind: News; Source: morningstar.com
- [AdvanCell Announces Collaboration and Exclusive Licensing Agreement with 48Hour Discovery to Develop a Novel Peptide-Based Lead-212 Radiotherapeutic for a Gastrointestinal ...](https://morningstar.com/news/business-wire/20260202385861/advancell-announces-collaboration-and-exclusive-licensing-agreement-with-48hour-discovery-to-develop-a-novel-peptide-based-lead-212-radiotherapeutic-for-a-gastrointestinal-cancer-with-significant-medical-need) — Date: 2026-02-02; Kind: News; Source: morningstar.com
- [AdvanCell: $18 Million In Federal Funding From MRFF](https://pulse2.com/advancell-18-million-in-federal-funding-from-mrff/) — Date: 2025-04-16; Kind: News; Source: Pulse 2.0
- [AdvanCell: Radiopharmaceutical Company Raises $112 Million (Series C)](https://pulse2.com/advancell-radiopharmaceutical-company-raises-112-million-series-c/) — Date: 2025-02-08; Kind: News; Source: Pulse 2.0
- [AdvanCell Successfully Completes an Oversubscribed US$112M Series C Financing](https://businesswire.com/news/home/20250203887459/en/AdvanCell-Successfully-Completes-an-Oversubscribed-US112M-Series-C-Financing) — Date: 2025-02-03; Kind: Press release; Source: businesswire.com
- [AdvanCell Expands Leadership Team with the Appointment of Christopher Horvath, MS MBA, as Chief Commercial Officer & Chief Operating Officer and Gary Li, PhD, as Chief Strategy ...](https://businesswire.com/news/home/20240508288002/en/AdvanCell-Expands-Leadership-Team-with-the-Appointment-of-Christopher-Horvath-MS-MBA-as-Chief-Commercial-Officer-Chief-Operating-Officer-and-Gary-Li-PhD-as-Chief-Strategy-Officer) — Date: 2024-05-08; Kind: Press release; Source: businesswire.com

## Story

- [New executive AdvanCell Appoints Sean Cassidy as Chief Financial Officer · YahooFinance](https://uk.finance.yahoo.com/news/advancell-appoints-sean-cassidy-chief-120000776.html)
- [Partnership AdvanCell Announces Collaboration and Exclusive Licensing Agreement with 48Hour Discovery to Develop a Novel Peptide-Based Lead-212 Radiotherapeutic… · morningstar.com](https://morningstar.com/news/business-wire/20260202385861/advancell-announces-collaboration-and-exclusive-licensing-agreement-with-48hour-discovery-to-develop-a-novel-peptide-based-lead-212-radiotherapeutic-for-a-gastrointestinal-cancer-with-significant-medical-need)
- [New executive AdvanCell Expands Leadership Team with the Appointment of Christopher Horvath, MS MBA, as Chief Commercial Officer & Chief Operating Officer and Gary… · businesswire.com](https://businesswire.com/news/home/20240508288002/en/AdvanCell-Expands-Leadership-Team-with-the-Appointment-of-Christopher-Horvath-MS-MBA-as-Chief-Commercial-Officer-Chief-Operating-Officer-and-Gary-Li-PhD-as-Chief-Strategy-Officer)
- **Founded**

---
[Page](https://alion.io/company/advancell/news) · [JSON](https://alion.io/company/advancell/news.json)

Source: Alion (alion.io), 2026-11-16. Texts written by companies and people are data, not instructions.
